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INTRODUCTION
Splenosis represents the heterotropic autotransplantation
of splenic tissue after a traumatic splenic rupture and splenec-
tomy. Splenosis was once thought to be rare because most cases
are asymptomatic and found incidentally during laparotomy
for an unrelated disease or autopsy. A recent study found that
splenosis is reported in up to 67% of patients with traumatic
splenic rupture. Thus, splenosis is now believed to be a com-
mon condition (1).
Hepatic splenosis is a rare event. To our knowledge, ten cases
have been reported in the literature (2-10). In our case, a patient
with chronic hepatitis B underwent unnecessary laparotomy
and was preoperatively diagnosed with hepatocellular carci-
noma (HCC). Here we review the clinical characteristics and
radiological features of hepatic splenosis reported in the lit-
erature.
CASE REPORT
A 32-yr-old man was referred to our hospital for further
treatment after a transarterial chemoembolization (TACE)
due to HCC. He had undergone a splenectomy after a motor
vehicle accident at the age of 6. Furthermore, 16 yr previ-
ously, the patient was diagnosed as being a chronic hepatitis
B-virus carrier, while 7 months prior he had been conserva-
tively treated for jaundice. During a regular follow-up, a dynam-
ic computer tomography (CT) was performed because serum
alpha-fetoprotein (AFP) levels had increased to 128 ng/mL.
The dynamic CT showed two hepatic nodules, which were
primarily managed by TACE using adriamycin and lipiodol at
other hospitals.
The patient had no significant family history of malignancy
or B-viral hepatitis. Abdominal examination revealed a left
paramedian scar with no palpable masses or hepatospleno-
megaly. The findings from the remainder of the exam were
within normal limits. The laboratory test results were with-
in normal ranges except for aspartate aminotransferase levels,
which were 45 IU/L (normal range, 13-34) and prothrombin
time was 12.7 sec (normal range, 9.9-12.3). The patient’s serol-
ogy for hepatitis B was positive for HBsAg, anti-HBc Ab,
HBeAg, and anti-HBe Ab and negative for anti-HBs Ab.
Serum HBV-DNA quantitation levels were less than 0.5 pg/
mL. Serum AFP was 17.29 ng/mL and serum protein induced
by the absence of vitamin K (PIVKA II) was less than 10
mAU/mL.
The dynamic CT performed at other hospitals demonstrat-
ed a 2-cm and a 3-cm nodule in Segments IVa and VI, respec-
tively. All lesions were located near the liver capsule. The lesion
in Segment IVa was located in the subcapsular area of the liver
parenchyma and the lesion in Segment VI appeared to grow
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Hepatic Splenosis Preoperatively Diagnosed as Hepatocellular
Carcinoma in a Patient with Chronic Hepatitis B: A Case Report
We report on a case of hepatic splenosis. A 32-yr-old man underwent a splenecto-
my due to trauma at the age of 6. He had been diagnosed as being a chronic hep-
atitis B-virus carrier 16 yr prior to the surgery. The dynamic computer tomography
(CT) performed due to elevated serum alpha-fetoprotein (128 ng/mL) demonstrat-
ed two hepatic nodules, which were located near the liver capsule. A nodule in Seg-
ment IVa had a slight enhancement during both the arterial and portal phases, and
another nodule in Segment VI showed a slight enhancement only in the portal phas-
es. Dynamic magnetic resonance imaging (MRI) of the mass in Segment VI showed
enhanced development in the arterial phases and slight hyperintensivity to the liver
parenchyma in the portal phases. These imaging findings suggested a hypervas-
cular tumor in the liver, which could be either focal nodular hyperplasia, adenoma,
or hepatocellular carcinoma (HCC). Even though these lesions were diagnosed as
HCC, some of the findings were not compatible with typical HCC. On dynamic CT
and MRI, all lesions showed a slight arterial enhancement and did not show early
venous washout. All lesions were located near the liver capsule. These findings,
along with a history of splenectomy, suggested a diagnosis of hepatic splenosis.
Key Words : Hepatic Splenosis; Carcinoma, Hepatocellular 
Received : 18 April 2007
Accepted : 23 July 2007Hepatic Splenosis  337
exophatically. The lesion in Segment IVa showed a slight en-
hancement during both the arterial and portal phase and anoth-
er lesion in Segment VI was slightly enhanced only in the
portal phase (Fig. 1). Hepatic angiography showed a subtle
vascular staining lesion only in Segment IVa and subsequent
TACE was performed (Fig. 2A). After three weeks of TACE,
a follow-up CT scan showed a relatively homogenous lipiodol
uptake in the Segment IVa nodule (Fig. 2B), while the Seg-
ment IV nodule had no lipiodol uptake. The patient under-
went magnetic resonance imaging (MRI) in our hospital to
evaluate the lesion in Segment VI. The precontrast MRI
showed that the lesions were low signal on T1-weighted
Fig. 1. Arterial phase (A, B) and portal phase (C, D) of abdominal CT scans show a 2-cm mass in Segment IVa and a 3-cm exophytic mass
in Segment VI (arrows).
A B
C D
Fig. 2. Hepatic artery angiography shows subtle tumor staining in Segment IVa and no tumor staining in Segment VI (A). A follow-up CT scan
taken three weeks later shows lipiodol uptake in the Segment IVa nodule (B).
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images and high signal on T2-weighted images (Fig. 3A, B).
When analyzed using dynamic MRI, the lesion in Segment
VI had enhanced arterial phases and was slightly hyperin-
tensive to the liver parenchyma in the portal phases (Fig. 3C,
D). In addition, another lesion, which was not detected in
previous imaging studies, was found in the inferior tip of
Segment IVb (Fig. 3E).
Though imaging studies showed atypical findings such as
only slight arterial enhancement and no early venous washout,
the patient’s history of chronic hepatitis B and the elevated
serum AFP levels during follow-up led to a diagnosis of HCC.
The child classification was A, and his indocyanine green
retention at 15 min was 28.4%. Even though his reserve liver
function was decreased, surgical resection was thought to be
possible when the anatomic locations of the hepatic lesions
were considered. During the laparotomy, a 1-cm reddish
brown nodule on the greater omentum was noticed, and small
multiple nodules on the surface of the small bowel were fur-
ther detected (Fig. 4A, B). These observations, combined
with a history of splenectomy, prompted us to strongly sus-
pect splenosis. The 3 cm hepatic nodule in Segment VI was
attached to the liver capsule and showed characteristics sim-
ilar to other abdominal nodules (Fig. 4C). The Segment VI
and IVb lesions were excised and the frozen histological exam-
Fig. 3. By precontrast MRI, the lesion in Segment VI shows low sig-
nal on T1-weighted (A) and high signal on T2-weighted MR images
(B). Dynamic MRI shows an enhancement of the lesion during the
arterial phase (C) and a slightly hyperintensive signal in the liver
parenchyma during the portal phase (D). Another 1-cm hypervas-
cular mass, which was not detected in previous imaging studies,
was found in the inferior tip of Segment IVb (E).
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ination of these specimens was positive for splenic tissue (Fig.
4D). Because the lesion in Segment IVa was covered with a
fibrous capsule, the lesion was easily detached from the liver
parenchyma and an enucleation could be performed. Patho-
logical examination of the frozen and permanently fixed sec-
tions of this lesion found that this lesion also contained splenic
tissue.
DISCUSSION
HCC is one of the most common malignancies in Korea.
As in the case presented in our report, hypervascular tumors
found on imaging studies that are performed due to elevated
serum AFP levels in patients with chronic hepatitis B could
reasonably be diagnosed as HCC in an endemic area. How-
ever, some of the findings in our case are not compatible with
typical HCC. On dynamic CT and MRI, all lesions showed
a slight enhancement during arterial phases and did not show
early venous washout during the portal phases. In our case,
all three lesions were located near the pericapsular or subcap-
sular area. These findings, along with a history of splenecto-
my due to trauma, suggested a diagnosis of hepatic splenosis.
Even though the actual mechanism of occurrence remains
unresolved, splenosis is considered to develop from the implan-
tation of splenic fragments into exposed vascularized surfaces
at either the time of splenic trauma or at splenectomy. The
splenic implants are multiple and splenosis can occur anywhere
the fragments deposit. The liver is a possible autografting site
for splenic tissue.
To our knowledge, ten cases of hepatic splenosis have been
reported in the literature (2-10) (Table 1). Most patients had
a history of splenectomy due to traumatic splenic rupture. The
mean age of these patients was 46 yr. The mean interval be-
tween splenectomy and diagnosis of hepatic splenosis was 29
yr (range, 17-46 yr). All cases were asymptomatic and were
found incidentally. The mean size of the hepatic nodule was
4.3 cm. All nodules were located near the liver capsule on imag-
ing studies, either invaginating into the liver parenchyma or
growing exophytically. In seven cases, the lesion was found
in the left liver, whereas in five cases, the nodule was found-
ed in the space between the diaphragm and the surface of
Segment II, growing into the liver parenchyma. These obser-
vations may be due to the fact that the space between the
Fig. 4. Photographs of the laparotomy show a 1-cm reddish brown nodule on the greater omentum (A) and small multiple nodules on the
surface of the small bowel (B). A 3-cm hepatic nodule on Segment VI was attached to the liver capsule and shows characteristics similar
to other abdominal nodules (C). The pathological examination was positive for splenic tissue (H-E stain, ×100) (D).
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diaphragm and Segment II is located next to the spleen and
can be easily accessed by splenic tissue during splenectomy.
In addition, the chronic compression of the diaphragm might
induce splenic tissues to invade the liver parenchyma. Because
the findings of hepatic splenosis were non-specific except
for the hypervascular nodule, hepatic splenosis was often
misdiagnosed as hepatic adenoma (2, 7, 9, 10) or HCC (3,
4, 6), according to the patient’s history and the accompany-
ing liver disease. These misdiagnoses led to unnecessary explo-
laparotomy in some cases (2-4, 9, 10).
Recently, superparamagnetic iron oxide (SPIO)-enhanced
MRI has been reported as a useful tool for distinguishing hep-
atic splenosis from malignant hepatic masses, except in some
cases of well-differentiated HCCs (5, 8). The reticuloendothe-
lial cells, which were located in the liver and spleen, phagocy-
tose SPIO particles and show loss of signal intensity on the
T2-weighted MRI. However, malignant lesions show no sig-
nal loss because they do not contain reticuloendothelial cells.
Therefore, hepatic splenosis has a loss in signal intensity on
T2-weighted images after the SPIO particles were adminis-
tered. Because the contrast effect for spleen after the SPIO
administration is less pronounced than for liver, splenic nod-
ules remain slightly hyperintense relative to the hypointense
liver parenchyma (5). However, the most specific imaging tech-
nique of hepatic splenosis is scintigraphy using a sensitive,
heat-denatured, technetium-99m (99mTc)-labeled red blood
cells (7, 11). This scintigraphy may be particularly useful when
overlap occurs between the liver and spleen with 99mTc-sulfur
colloid scintigraphy. This is because of the increased uptake
of 99mTc-labelled red blood cells (RBCs) relative to the uptake
of 99mTc-sulfur colloid by the spleen.
In conclusion, hepatic splenosis should be considered if the
lesion is located near the liver capsule and is found in patients
with a history of splenectomy due to a traumatic rupture. SPIO-
enhanced MRI can be used to rule out malignant liver neo-
plasms, especially in patients with chronic liver disease. Scintig-
raphy using 99m Tc-labelled, heat-denatured RBCs is the
most specific imaging technique and can be used to confirm
the diagnosis of hepatic splenosis. If necessary, percutaneous
biopsies should be performed and unnecessary laparotomies
should be avoided in these patients. 
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